Related references
Note: Only part of the references are listed.Sodium channel Nav1.8 Emerging links to human disease
Chongyang Han et al.
NEUROLOGY (2016)
Pharmacotherapy for Pain in a Family With Inherited Erythromelalgia Guided by Genomic Analysis and Functional Profiling
Paul Geha et al.
JAMA NEUROLOGY (2016)
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release
Aristos J. Alexandrou et al.
PLOS ONE (2016)
Adenosine Monophosphate-activated Protein Kinase Regulates Interleukin-1β Expression and Glial Glutamate Transporter Function in Rodents with Neuropathic Pain
Dylan W. Maixner et al.
ANESTHESIOLOGY (2015)
Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin
Junxiong Ma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
NaV 1.9: a sodium channel linked to human pain
Sulayman D. Dib-Hajj et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Painful peripheral neuropathy and sodium channel mutations
Janneke G. J. Hoeijmakers et al.
NEUROSCIENCE LETTERS (2015)
The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model
Qi-Liang Mao-Ying et al.
PLOS ONE (2014)
Significant Determinants of Mouse Pain Behaviour
Michael S. Minett et al.
PLOS ONE (2014)
Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain
Jacinthe Gingras et al.
PLOS ONE (2014)
Evidence for the Analgesic Activity of Resveratrol in Acute Models of Nociception in Mice
Karen O. Bazzo et al.
JOURNAL OF NATURAL PRODUCTS (2013)
The NaV1.7 sodium channel: from molecule to man
Sulayman D. Dib-Hajj et al.
NATURE REVIEWS NEUROSCIENCE (2013)
mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK
Ohannes K. Melemedjian et al.
PAIN (2013)
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels
Ken McCormack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy
Catharina G. Faber et al.
ANNALS OF NEUROLOGY (2012)
AMP-activated protein kinase: new regulation, new roles?
David Carling et al.
BIOCHEMICAL JOURNAL (2012)
Neurological perspectives on voltage-gated sodium channels
Niels Eijkelkamp et al.
BRAIN (2012)
Membrane properties and electrogenesis in the distal axons of small dorsal root ganglion neurons in vitro
Dmytro V. Vasylyev et al.
JOURNAL OF NEUROPHYSIOLOGY (2012)
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain
Dipti V. Tillu et al.
MOLECULAR PAIN (2012)
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons
Michael S. Minett et al.
NATURE COMMUNICATIONS (2012)
Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
Yang Yang et al.
NATURE COMMUNICATIONS (2012)
A Point Mutation at F1737 of the Human Nav1.7 Sodium Channel Decreases Inhibition by Local Anesthetics
Jacqueline Panigel et al.
JOURNAL OF NEUROGENETICS (2011)
Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
Ohannes K. Melemedjian et al.
MOLECULAR PAIN (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Sodium Channels in Normal and Pathological Pain
Sulayman D. Dib-Hajj et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 33 (2010)
Substituted biaryl pyrazoles as sodium channel blockers
Sriram Tyagarajan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
ERK1/2 Mitogen-Activated Protein Kinase Phosphorylates Sodium Channel Nav1.7 and Alters Its Gating Properties
Severine Stamboulian et al.
JOURNAL OF NEUROSCIENCE (2010)
Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability
Mark Estacion et al.
MOLECULAR PAIN (2010)
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Marina Asiedu et al.
PAIN (2010)
A Novel Nav1.7 Mutation Producing Carbamazepine-Responsive Erythromelalgia
Tanya Z. Fischer et al.
ANNALS OF NEUROLOGY (2009)
Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatment
Sulayman D. Dib-Hajj et al.
BRAIN RESEARCH REVIEWS (2009)
Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells
Tao Pang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ProTx-II, a Selective Inhibitor of Nav1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors
William A. Schmalhofer et al.
MOLECULAR PHARMACOLOGY (2008)
Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7
Brande S. Williams et al.
BIOCHEMISTRY (2007)
Benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
Scott B. Hoyt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The roles of sodium channels in nociception: Implications for mechanisms of pain
Theodore R. Cummins et al.
PAIN (2007)
A stop codon mutation in SCN9A causes lack of pain sensation
Sultan Ahmad et al.
HUMAN MOLECULAR GENETICS (2007)
Discovery of a novel class of benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
Scott B. Hoyt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat
Michael F. Jarvis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations
Y. P. Goldberg et al.
CLINICAL GENETICS (2007)
Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons
Anthony M. Rush et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
Sporadic onset of erythermalgia:: A gain-of-function mutation in Nav1.7
CY Han et al.
ANNALS OF NEUROLOGY (2006)
Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons
SD Dib-Hajj et al.
BRAIN (2005)
Resveratrol inhibits Na+ currents in rat dorsal root ganglion neurons
HI Kim et al.
BRAIN RESEARCH (2005)
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain
MA Nassar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons
RI Herzog et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions
MC Araujo et al.
PAIN (2003)
Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain
LJ Smith et al.
PAIN (2002)
Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw
M Gentilli et al.
LIFE SCIENCES (2001)